Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Jennifer L. Taylor-Cousar

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Taylor-Cousar, Jennifer

One or more keywords matched the following items that are connected to Taylor-Cousar, Jennifer

Item Type	Name
Concept	Quinolones
Academic Article	Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Academic Article	Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States.
Academic Article	Pregnancy among cystic fibrosis women in the era of CFTR modulators.
Academic Article	Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR.
Academic Article	Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.
Academic Article	Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR.
Academic Article	VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Academic Article	VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Academic Article	Positive clinical response to ivacaftor treatment in an individual with the CFTR genotype F508del/V456A.
Academic Article	Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.
Academic Article	The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy.
Academic Article	Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
Academic Article	Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
Academic Article	Development of elexacaftor - tezacaftor - ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis.
Academic Article	A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.
Academic Article	Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation.
Academic Article	Combination CFTR modulator therapy in children and adults with cystic fibrosis.
Academic Article	Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design.
Academic Article	The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis.
Academic Article	CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis.
Academic Article	Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.

Search Criteria

4 Quinolones